Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Revenue projections:

Revenue projections for MEDANTA
Revenue projections for MEDANTA

MEDANTA's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 2.478000
forwardPE 41.406178
debtToEquity 21.188000
earningsGrowth -0.204000
revenueGrowth 0.128000
grossMargins 0.538440
operatingMargins 0.188390
trailingEps 17.940000
forwardEps 23.410000

MEDANTA's current ratio being 2.478 shows it has more than enough assets to cover its short-term debts. The company's liquidity position is strong, with ample cash reserves available to meet its immediate financial obligations without strain.
MEDANTA's low Debt-to-Equity ratio reflects the company's conservative use of debt. This shows that it isn't over-leveraged, reducing financial risk and indicating a stable financial structure, which is a positive signal for investors concerned about excessive debt burdens.
MEDANTA's low earnings and revenue growth highlight potential profit shrinkage. This suggests that the company may struggle to maintain its financial performance, raising concerns about its future profitability.
MEDANTA's negative gross and operating margins point to financial difficulties, as the company is unable to generate profit from its core operations or production. This could signal broader problems in cost management or declining sales.
Global Health Limited's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting Global Health Limited to generate stronger earnings compared to the previous financial year.

Price projections:

Price projections for MEDANTA
Price projections for MEDANTA

MEDANTA's price projections have been steadily revised down, pointing to declining confidence in the company's outlook. This suggests that analysts are becoming more conservative in their expectations for MEDANTA's future performance.

Recommendation changes over time:

Recommendations trend for MEDANTA
Recommendations trend for MEDANTA


MEDANTA has been receiving a buy bias from analysts, indicating confidence in its investment potential. This could drive more investors to view MEDANTA as a reliable choice for their money, offering a promising avenue for future growth and financial gains.